These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6428368)

  • 1. [Moderate supplementation of potassium in essential hypertension].
    MacGregor GA; Smith SJ; Markandu ND; Banks RA; Sagnella GA
    Arch Mal Coeur Vaiss; 1984 Apr; 77 Spec No():93-100. PubMed ID: 6428368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Moderate potassium supplementation in essential hypertension.
    MacGregor GA; Smith SJ; Markandu ND; Banks RA; Sagnella GA
    Lancet; 1982 Sep; 2(8298):567-70. PubMed ID: 6125727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does increasing potassium intake lower blood pressure in essential hypertension?
    MacGregor GA; Smith SJ; Markandu ND; Sagnella GA
    J Cardiovasc Pharmacol; 1984; 6 Suppl 1():S244-9. PubMed ID: 6204149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Moderate potassium chloride supplementation in essential hypertension: is it additive to moderate sodium restriction?
    Smith SJ; Markandu ND; Sagnella GA; MacGregor GA
    Br Med J (Clin Res Ed); 1985 Jan; 290(6462):110-3. PubMed ID: 3917702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antihypertensive effect of oral potassium aspartate supplementation in mild to moderate arterial hypertension.
    Franzoni F; Santoro G; Carpi A; Da Prato F; Bartolomucci F; Femia FR; Prattichizzo F; Galetta F
    Biomed Pharmacother; 2005; 59(1-2):25-9. PubMed ID: 15740932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of blood pressure with calcium and potassium supplementation in children with salt sensitivity: a 2-year double-blinded placebo-controlled trial.
    Mu JJ; Liu ZQ; Liu WM; Liang YM; Yang DY; Zhu DJ; Wang ZX
    J Hum Hypertens; 2005 Jun; 19(6):479-83. PubMed ID: 15759021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sodium restriction and blood pressure in hypertensive type II diabetics: randomised blind controlled and crossover studies of moderate sodium restriction and sodium supplementation.
    Dodson PM; Beevers M; Hallworth R; Webberley MJ; Fletcher RF; Taylor KG
    BMJ; 1989 Jan; 298(6668):227-30. PubMed ID: 2493869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multicentric, clinical trial of S-Amlodipine 2.5 mg versus Amlodipine 5 mg in the treatment of mild to moderate hypertension--a randomized, double-blind clinical trial.
    Pathak L; Hiremath ; Kerkar PG; Manade VG
    J Assoc Physicians India; 2004 Mar; 52():197-202. PubMed ID: 15636308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sodium and potassium intake in the management of high blood pressure.
    MacGregor GA
    J Clin Hypertens; 1986 Jun; 2(2):132-40. PubMed ID: 3531413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double-blind randomised crossover trial of moderate sodium restriction in essential hypertension.
    MacGregor GA; Markandu ND; Best FE; Elder DM; Cam JM; Sagnella GA; Squires M
    Lancet; 1982 Feb; 1(8268):351-5. PubMed ID: 6120346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term potassium supplementation lowers blood pressure in elderly hypertensive subjects.
    Fotherby MD; Potter JF
    Int J Clin Pract; 1997 Jun; 51(4):219-22. PubMed ID: 9287262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Moderate sodium restriction with angiotensin converting enzyme inhibitor in essential hypertension: a double blind study.
    MacGregor GA; Markandu ND; Singer DR; Cappuccio FP; Shore AC; Sagnella GA
    Br Med J (Clin Res Ed); 1987 Feb; 294(6571):531-4. PubMed ID: 3103761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of oral potassium citrate/bicarbonate on blood pressure in essential hypertension during unrestricted salt intake.
    Overlack A; Conrad H; Stumpe KO
    Klin Wochenschr; 1991; 69 Suppl 25():79-83. PubMed ID: 1921255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of oral calcium supplementation on blood pressure in population].
    Pan Z; Zhao L; Guo D; Yang R; Xu C; Wu X
    Zhonghua Yu Fang Yi Xue Za Zhi; 2000 Mar; 34(2):109-12. PubMed ID: 11860914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of salt intake on endothelium-derived factors in a group of patients with essential hypertension.
    Bragulat E; de la Sierra A; Antonio MT; Jiménez W; Urbano-Márquez A ; Coca A
    Clin Sci (Lond); 2001 Jul; 101(1):73-8. PubMed ID: 11410117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Long term observation in effects of potassium and calcium supplementation on arterial blood pressure and sodium metabolism in adolescents with higher blood pressure].
    Mu JJ; Liu ZQ; Yang J; Liang YM; Zhy DJ; Wang YX; Gao BL; Zhang XL; Ji HC; Xu XL
    Zhonghua Yu Fang Yi Xue Za Zhi; 2003 Mar; 37(2):90-2. PubMed ID: 12839657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of sibutramine for weight loss in obese patients with hypertension well controlled by beta-adrenergic blocking agents: a placebo-controlled, double-blind, randomised trial.
    Sramek JJ; Leibowitz MT; Weinstein SP; Rowe ED; Mendel CM; Levy B; McMahon FG; Mullican WS; Toth PD; Cutler NR
    J Hum Hypertens; 2002 Jan; 16(1):13-9. PubMed ID: 11840225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of moderate dietary sodium restriction on patients with mild hypertension in general practice.
    Watt G; Hart JT; Foy C
    J Hypertens Suppl; 1983 Dec; 1(2):18-20. PubMed ID: 6400113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does dietary recall adequately assess sodium, potassium, and calcium intake in hypertensive patients?
    Leiba A; Vald A; Peleg E; Shamiss A; Grossman E
    Nutrition; 2005 Apr; 21(4):462-6. PubMed ID: 15811766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lifestyle modifications to prevent and control hypertension. 5. Recommendations on dietary salt. Canadian Hypertension Society, Canadian Coalition for High Blood Pressure Prevention and Control, Laboratory Centre for Disease Control at Health Canada, Heart and Stroke Foundation of Canada.
    Fodor JG; Whitmore B; Leenen F; Larochelle P
    CMAJ; 1999 May; 160(9 Suppl):S29-34. PubMed ID: 10333851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.